U.S. markets close in 1 hour 54 minutes
  • S&P 500

    4,462.91
    +67.27 (+1.53%)
     
  • Dow 30

    34,857.76
    +599.44 (+1.75%)
     
  • Nasdaq

    15,074.49
    +177.64 (+1.19%)
     
  • Russell 2000

    2,263.87
    +45.31 (+2.04%)
     
  • Crude Oil

    73.30
    +1.07 (+1.48%)
     
  • Gold

    1,753.10
    -25.70 (-1.44%)
     
  • Silver

    22.70
    -0.20 (-0.88%)
     
  • EUR/USD

    1.1750
    +0.0054 (+0.46%)
     
  • 10-Yr Bond

    1.3930
    +0.0570 (+4.27%)
     
  • GBP/USD

    1.3735
    +0.0115 (+0.84%)
     
  • USD/JPY

    110.1900
    +0.4120 (+0.38%)
     
  • BTC-USD

    44,800.07
    +1,064.17 (+2.43%)
     
  • CMC Crypto 200

    1,123.54
    +14.62 (+1.32%)
     
  • FTSE 100

    7,078.35
    -5.02 (-0.07%)
     
  • Nikkei 225

    29,639.40
    -200.31 (-0.67%)
     

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of VRUS, WISH and OCGN

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·3 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NEW YORK, NY / ACCESSWIRE / June 21, 2021 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Verus International, Inc. (OTC PINK:VRUS)
Class Period: June 17, 2019 - November 8, 2020
Lead Plaintiff Deadline: June 22, 2021

The complaint alleges that during the class period Verus International, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) Verus lacked the requisite resources, infrastructure and/or expertise to exploit its Big League Foods brand and its MLB license; (ii) the company's issues in production ramp-up were not fully resolved to enable the company to fulfill customer orders; (iii) as a result, the company's prospects and outlook were not as represented; (iv) the company's internal controls for financial reporting and accounting were not sufficient with specific respect to stock-based compensation and classification of equity instruments; (v) as a result, the company's financial results, outlook and prospects were materially worse than represented; and (vi) as a result of the foregoing, the company's public statements were materially false and misleading at all relevant times.

Learn about your recoverable losses in VRUS: http://www.kleinstocklaw.com/pslra-1/verus-international-inc-loss-submission-form?id=17065&from=1

Contextlogic Inc. (NASDAQ:WISH)
This lawsuit is on behalf of investors who purchased WISH pursuant or traceable to the registration statement and prospectus issued in connection with ContextLogic's December 16, 2020 initial public stock offering or between December 16, 2020 and May 12, 2021.
Lead Plaintiff Deadline: July 16, 2021

In the registration statement and prospectus used to conduct the initial public offering and throughout the class period, defendants made materially false and misleading statements about the strength of ContextLogic's business operations and financial prospects by overstating its then-present monthly active users ("MAUs") and MAU growth trends.

Learn about your recoverable losses in WISH: https://www.kleinstocklaw.com/pslra-1/contextlogic-inc-loss-submission-form?id=17065&from=1

Ocugen, Inc. (NASDAQ:OCGN)
Class Period: February 2, 2021 - June 10, 2021
Lead Plaintiff Deadline: August 17, 2021

According to the complaint, Ocugen, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) the information submitted to the U.S. Food and Drug Administration ("FDA") was insufficient to support an Emergency Use Authorization ("EUA"), (ii) Ocugen would not file an EUA with the FDA, (iii) as a result of the foregoing, the Company's financial statements, as well as Defendants' statements about Ocugen's business, operations, and prospects, were false and misleading and/or lacked a reasonable basis.

Learn about your recoverable losses in OCGN: https://www.kleinstocklaw.com/pslra-1/ocugen-inc-loss-submission-form?id=17065&from=1

Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com

SOURCE: The Klein Law Firm



View source version on accesswire.com:
https://www.accesswire.com/652589/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-VRUS-WISH-and-OCGN